PureCycle Technologies, Inc. (PCT) is commercializing a patented dissolution recycling technology for polypropylene, restoring waste into like-new PureFive® resin. Reported approximately $8.4 million in revenues for the year ended December 31, 2025, compared to no revenues in 2024. Experienced an operating loss of $181.4 million in 2025, an increase from $145.4 million in 2024. Net loss for 2025 was $182.6 million, an improvement from $289.1 million in 2024, primarily due to changes in fair value of warrants. Successfully raised significant capital in 2025, including $33.0 million from common stock private placement, $36.9 million from Series A Bonds sales, and $300.0 million from Series B Convertible Perpetual Preferred Stock. The Ironton Facility achieved mechanical completion in 2023 and commenced pellet production but is not yet operating at full capacity due to intermittent mechanical challenges. Plans for global expansion include a 130 million pound per year facility in Thailand (operational late 2027), a 130 million pound per year facility in Belgium (operational mid to late 2028), and a redesigned 300 million pound per year facility in Augusta, Georgia (operational by 2030). Received additional FDA Letters of No Objection (LNOs) for PureFive® resin in food-contact applications, allowing use for all food types under various conditions. Recognized a $15.1 million write-down of long-lead equipment in 2025 due to redesign plans for the Augusta Facility and re-purposing equipment. Total consolidated indebtedness as of December 31, 2025, was $363.7 million. Cash and cash equivalents were $156.7 million as of December 31, 2025, up from $15.7 million in 2024. The company's going concern doubt has been alleviated for at least the next twelve months due to the Series B Preferred Stock funding.